4.5 Article

Molecular signatures for vaccine development

期刊

VACCINE
卷 33, 期 40, 页码 5256-5261

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2015.03.075

关键词

Signatures; Vaccination; Defense response

资金

  1. European Union's Seventh Framework Programme (EU FP7) project ADITEC [HEALTH-F4-2011-280873]
  2. EU Horizon 2020 project TBVAC 2020 [643381]
  3. Innovative Medicines Initiative (IMI) Joint Undertaking (JU) Biomarkers for Enhanced Vaccine Safety project BioVacSafe (IMI JU) [115308]
  4. Bill & Melinda Gates Foundation (BMGF) Grand Challenges (GC) in Global Health Program (BMGF GC6) [OPP 1055806, OPP 1065330]
  5. Bundesministerium fur Bildung und Forschung (BMBF) project Infect Control 2020

向作者/读者索取更多资源

The immune system has evolved complex and specialized mechanisms to mount specific defense responses against the various types of pathogens it encounters. For the development of new vaccines, it is crucial to gain a better understanding of what these mechanisms are and how they work. The field of vaccinology has adopted high-throughput profiling techniques to gain more detailed insights into the various immune responses elicited by different vaccines and natural infections. From all detailed transcriptional profiles generated today, a general picture of immunological responses emerges. First, almost every type of vaccine induces an early interferon-dominated signature. Second, different vaccine formulations induce distinct transcriptional signatures, representing the highly specialized defense mechanisms that must cope with the different pathogens and insults they cause. Transcriptional profiling has shifted its attention toward early molecular signatures, with a growing awareness that early innate responses are likely critical instructors for the development of adaptive immunity at later time points. (C) 2015 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据